Recent

% | $
Quotes you view appear here for quick access.

SAVİENT PHARM AŞ Message Board

  • biotekdisaster biotekdisaster Aug 30, 2013 1:28 AM Flag

    Krystexxa could well end up to be the Viagra of Savient, it is going to be well over $35....

    A post from bbking2003 at Monday, March 04, 2013 1:20:49 PM
    Krystexxa could well end up to be the Viagra of Savient. It may possibly even be better? Competitors in the gout treatment arena work by lowering the amount of Uric acid as a percent. They still allow unacceptable amounts of uric acid to pass through the Kidneys, though not as much. That is small consolation because every drop of uric acid that flows through an already compromised kidney is one step closer to dialysis.
    It turns out that if you can delay or improve the prospects for someone suffering from Kidney disease, and limit their need for dialysis you can save the healthcare system gobs of money. To say billions worldwide is not hyperbolic

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think PR says LABEL EXPANSION for KIDNEY DISEASE and DIALYSIS is in progress, We have opportunity to get additional 90 to 120 Million dollar revenue from SOBI’s KINERET and ready to increase our stock price WELL OVER $35...

    • Well story is this, if you like it or not, this stock is going to be well over $35.

      • 3 Replies to jumbalyashrimp
      • This is the best Pharma company in the market. It has a huge potential, IMO this stock is going to be well over $35.

      • Addition to SOBO's KINERET, Krystexxa could well end up to be the Viagra of Savient. It may possibly even be better? Competitors in the gout treatment arena work by lowering the amount of Uric acid as a percent. They still allow unacceptable amounts of uric acid to pass through the Kidneys, though not as much. That is small consolation because every drop of uric acid that flows through an already compromised kidney is one step closer to dialysis.
        It turns out that if you can delay or improve the prospects for someone suffering from Kidney disease, and limit their need for dialysis you can save the healthcare system gobs of money. To say billions worldwide is not hyperbolic

      • It is very nice company.. IMO it is going to be well over $35

    • The following post is past and copied from bbking2003. "Krystexxa could well end up to be the Viagra of Savient. It may possibly even be better? Competitors in the gout treatment arena work by lowering the amount of Uric acid as a percent. They still allow unacceptable amounts of uric acid to pass through the Kidneys, though not as much. That is small consolation because every drop of uric acid that flows through an already compromised kidney is one step closer to dialysis.
      It turns out that if you can delay or improve the prospects for someone suffering from Kidney disease, and limit their need for dialysis you can save the healthcare system gobs of money. To say billions worldwide is not hyperbolic" IMO we should add SOBI's kineret to on it. Estimated revenue from kineret is around 100 million$, so that label expansion + this additional annual revenue IMO is going to be VIAGRA of the SAVIENT.

    • IMO Savient VIAGRA is going to be label expansion for KRYSTEXXA to KIDNEY DISEASE and DIALYSIS, stock price well over $35.

    • Paper related with KRYSTEXXA to KIDNEY DISEASE and DIALYSIS is going to be Viagra of Savient, IMO it is going to be any seconds.

    • SOBI’s KINERET has a potential of over $90 Millions annual revenue in the USA, IMO, will be great Q3

    • Sobi is going to be Viagra of Savient

    • Especially after SOBI’s KINERET which has a potential of over $90 Millions annual revenue in the USA

    • Just a reminder for the post from bbking2003 at Monday, March 04, 2013 1:20:49 PM
      Krystexxa could well end up to be the Viagra of Savient. It may possibly even be better? Competitors in the gout treatment arena work by lowering the amount of Uric acid as a percent. They still allow unacceptable amounts of uric acid to pass through the Kidneys, though not as much. That is small consolation because every drop of uric acid that flows through an already compromised kidney is one step closer to dialysis.
      It turns out that if you can delay or improve the prospects for someone suffering from Kidney disease, and limit their need for dialysis you can save the healthcare system gobs of money. To say billions worldwide is not hyperbolic. I am 100 % agree with this post.

    • This is going bankrupt. 35 cents and on the pinks. Imho.

 
SVNTQ
0.00(0.00%)